24,25 dihydroxyvitamin D supplementation corrects hyperparathyroidism and improves skeletal abnormalities in X-linked hypophosphatemic rickets - A clinical research center study

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 6, 1996, Pages 2381-2388

  Carpenter, Thomas O ^a   Keller, Marc ^a   Schwartz, Dana ^a   Mitnick, Maryann ^a   Smith, Cynthia ^a   Ellison, Alice ^a   Carey, Dennis ^d   Comite, Florence ^a   Horst, Ronald ^c   Travers, Rose ^b   Glorieux, Francis H ^b   Gundberg, Caren M ^a   Poole, A Robin ^b   Insogna, Karl L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c NATIONAL ANIMAL DISEASE CENTER   (United States)

^d SCHNEIDER CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

24,25 DIHYDROXYVITAMIN D; CALCITRIOL; CALCIUM ION; CYCLIC AMP; DIHYDROTACHYSTEROL; PARATHYROID HORMONE; PHOSPHATE; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; BONE BIOPSY; CALCIUM HOMEOSTASIS; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; MALE; ORAL DRUG ADMINISTRATION; OSTEOMALACIA; PRIORITY JOURNAL; VITAMIN D RESISTANT RICKETS; VITAMIN INTAKE;

24,25-DIHYDROXYVITAMIN D 3; ADOLESCENT; ADULT; BONE AND BONES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERPARATHYROIDISM; HYPOPHOSPHATEMIA, FAMILIAL; LINKAGE (GENETICS); MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; X CHROMOSOME;

ANIMALIA; MURINAE;

EID: 8944219775     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.6.2381     Document Type: Article

References (34)

1. Rasmussen H, Tenenhouse HS. 1995 Mendelian hypophosphatemias, In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The molecular and metabolic basis of inherited disease, 7th ed. New York: McGraw-Hill; 3717-3745.
2. Glorieux FH, Marie PJ, Pettifor JM, Delvin EE. 1980 Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D resistant rickets. N Engl J Med. 303:1023-1031.
3. 3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia. J Clin Invest. 66:1020-1032.
4. 3 therapy in symptomatic adults with X-linked hypophosphatemic rickets. J Clin Endocrinol Metab. 75:879-885.
5. Stickler GB, Morgenstern BZ. 1989 Hypophosphatemic rickets: final height and clinical symptoms in adults. Lancet. 902-905.
6. Reusz GS, Hoyer PF, Lucas M, Krohn HP, Ehrich JHH, Brodehl J. 1990 X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis. Arch Dis Child. 65:1125-1128.
7. Carpenter TO, Mitnick MA, Ellison A, Smith C, Insogna KL. 1994 Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia. J Clin Endocrinol Metab. 78:1378-1383.
8. Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M. 1991 Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med. 325: 1843-1848.
9. Endo H, Kiyoki M, Kawashima K, Naguchi T, Hashimoto Y. 1980 Vitamin D metabolites and PTH synergistically stimulate bone formation. Nature. 286:262-264.
10. Tam CS, Heersche JNM, Jones G, Murray TM, Rasmussen H. 1986 The effect of vitamin D on bone in vivo. Endocrinology. 118:2217-2224.
11. Atkin I, Pita JC, Ornoy A, Agundez A, Castiglione G, Howell DS. 1985 Effects of vitamin D metabolites on healing of low phosphate vitamin D-deficient induced rickets in rats. Bone. 6:113-123.
12. 3 in the hypophosphatemic mouse. J Bone Miner Res. 9:1967-1975.
13. Henry HL, Taylor AN, Norman AW. 1977 Response of chick parathyroid glands to the vitamin D metabolites, 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol. J Nutr. 107:1918-1926.
14. Canterbury JM, Lerman S, Claflin AJ, Henry H. 1978 Inhibition of parathyroid hormone secretion by 25-hydroxycholecalciferol and 24,25-dihydroxycholecalciferol in the dog. J Clin Invest. 61:1375-1383.
15. 3 dihydroxylated metabolites on parathyroid hormone in the rat. Miner Electrolyte Metab. 7:67-75.
16. Parfitt AM, Drezner MK, Glorieux FH, et al. 1987 Bone histomorphometry: standardization of nomenclature, symbols and units. J Bone Miner Res. 2:595-610.
17. Horst RL, Littledike ET, Gray RW, Napoli JL. 1981 Impaired 24,25-dihydroxyvitamin D production in anephric man and pig. J Clin Invest. 67: 274-280.
18. Walton RJ, Bijvoet OLM. 1973 Nomogram for derivation of renal threshold phosphate concentration. Lancet. 2:309-310.
19. Broadus AE. 1979 Nephrogenous cyclic AMP as a parathyroid function test. Nephron. 23:136-141.
20. Gundberg CM, Hauschka PV, Lian JB, Gallop PM. 1984 Osteocalcin: isolation, characterization and detection. Methods Enzymol. 107:516-544.
21. Hinek A, Poole AR. 1988 The influence of vitamin D metabolites on the calcification of cartilage matrix and the C-propeptide of type II collagen (chondrocalcin). J Bone Miner Res. 3:421-429.
22. Carpenter TO, Insogna KL, Boulware SD, Mitnick MA. 1990 Vitamin D metabolism in chronic childhood hypoparathyroidism: evidence for a direct regulatory effect of calcium. J Pediatr. 116:252-257.
23. 3. Bone. 10:117-123.
24. 3. Calcif Tissue Int. 43:235-243.
25. Erben RG, Weiser H, Sinocatz F, Rambeck WA, Zucker H. 1992 Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats. Calcif Tissue Int. 50:228-236.
26. 3 administration in beagles. Calcif Tissue Int. 52: 49-56.
27. Miravet L, Guertis J, Redel J, Norman A, Ryckewaert A. 1981 Action of vitamin D metabolites on PTH secretion in man. Calcif Tissue Int. 33:191-194.
28. Varghese Z, Moorhead JF, Farrington K. 1992 Effect of 24,25-dihydroxycholecalciferol on intestinal absorption of calcium and phosphate and on parathyroid hormone secretion in chronic renal failure. Nephron. 60:286-291.
29. Balsan S, Tieder M. 1990 Linear growth in patients with hypophosphatemic vitamin D-resistant rickets: influence of treatment regimen and parental height. J Pediatr. 116:365-371.
30. Reitz RE, Weinstein RL. 1973 Parathyroid hormone secretion in familial vitamin D-resistant rickets. N Engl J Med. 289:941-945.
31. Lewy JE, Cabana EC, Repetto HA, Canterbury JM, Reiss E. 1972 Serum parathyroid hormone in hypophosphatemic vitamin D-resistant rickets. J Pediatr. 81:294-300.
32. Firth RG, Grant CS, Riggs BL. 1985 Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Am J Med. 78:669-763.
33. Rivkees SA, El-Hajj-Fuleihan G, Brown EM, Crawford JD. 1992 Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets. J Clin Endocrinol Metab. 75:1514-1518.
34. Knudtson J, Haise J, Monn E, et al. 1995 Autonomous hyperparathyroidism in X-linked hypophosphatemia. Clin Endocrinol (Oxf). 42:199-203.